Secukinumab for Acrodermatitis Continua of Hallopeau

JAMA Dermatol. 2017 Apr 1;153(4):336-337. doi: 10.1001/jamadermatol.2016.5059.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrodermatitis / diagnosis
  • Acrodermatitis / drug therapy*
  • Aged, 80 and over
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Biopsy
  • Foot Dermatoses / diagnosis
  • Foot Dermatoses / drug therapy*
  • Humans
  • Male
  • Skin / pathology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab